Optimal Role of the Nephrologist in the Intensive Care Unit

Blood Purification

Volumn 43, Issue 1-3, 2017, Pages 68-77

  Askenazi, D J ^a   Heung, Michael ^b   Connor, Michael J ^c   Basu, Rajit K ^d   Cerdá, Jorge ^e   Doi, Kent ^l   Koyner, Jay L ^f   Bihorac, Azra ^g   Golestaneh, Ladan ^h   Vijayan, Anitha ⁱ   Okusa, Mark D ^j   Faubel, Sarah ^k  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e ALBANY MEDICAL COLLEGE   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

^g UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^h ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

ⁱ WASHINGTON UNIVERSITY   (United States)

^j UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^k UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF TOKYO HOSPITAL   (Japan)

more..

Author keywords

Acute kidney injury; Critical care nephrology; Education; Quality Improvement; Renal replacement therapy

Indexed keywords

ACUTE GLOMERULONEPHRITIS; ARTICLE; BLOODSTREAM INFECTION; CLINICAL OUTCOME; CRITICALLY ILL PATIENT; DIALYSIS CATHETER; GENERAL PRACTITIONER; HUMAN; INTENSIVE CARE UNIT; KIDNEY INJURY; MORTALITY; NEPHROLOGIST; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; ACUTE KIDNEY INJURY; INTENSIVE CARE; NEPHROLOGY; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; PROCEDURES; PUBLIC RELATIONS; STANDARDS;

ACUTE KIDNEY INJURY; CRITICAL CARE; HUMANS; INTENSIVE CARE UNITS; INTERPROFESSIONAL RELATIONS; NEPHROLOGISTS; NEPHROLOGY; PRACTICE GUIDELINES AS TOPIC;

EID: 85001871684     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000452317     Document Type: Article

References (55)

1. Ronco C, Bellomo R: Critical care nephrology: the time has come. Nephrol Dial Transplant 1998;13:264-267.
2. Srisawat N, Kellum JA: Acute kidney injury: definition, epidemiology, and outcome. Curr Opin Crit Care 2011;17:548-555.
3. Goldstein SL: Fluid management in acute kidney injury. J Intensive Care Med 2014;29:183-189.
4. Davenport A, Bouman C, Kirpalani A, et al. Delivery of renal replacement therapy in acute kidney injury: what are the key issues? Clin J Am Soc Nephrol 2008;3:869-875.
5. Gaudry S, Hajage D, Schortgen F, et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 2016;375:122-133.
6. Chertow GM, Winkelmayer WC: Early to dialyze: healthy and wise? JAMA 2016;315:2171-2172.
7. Maddux FW, Nissenson AR: The evolving role of the medical director of a dialysis facility. Clin J Am Soc Nephrol 2015;10:326-330.
8. Schiller B: The medical director and quality requirements in the dialysis facility. Clin J Am Soc Nephrol 2015;10:493-499.
9. Rewa O, Mottes T, Bagshaw SM: Quality measures for acute kidney injury and continuous renal replacement therapy. Curr Opin Crit Care 2015;21:490-499.
10. Kee YK, Kim EJ, Park KS, et al. The effect of specialized continuous renal replacement therapy team in acute kidney injury patients treatment. Yonsei Med J 2015;56:658-665.
11. Eding DM, Jelsma LR, Metz CJ, et al. Innovative techniques to decrease blood exposure and minimize interruptions in pediatric continuous renal replacement therapy. Crit Care Nurse 2011;31:64-71.
12. Askenazi DJ, Selewski DT, Paden ML, et al. Renal replacement therapy in critically ill patients receiving extracorporeal membrane oxygenation. Clin J Am Soc Nephrol 2012;7:1328-1336.
13. Herrera-Gutiérrez ME, Seller-Pérez G, Lebrón-Gallardo M, et al. [Safety and efficacy of the MARS therapy applied by continuous renal replacement therapy (CRRT) monitors]. Med Intensiva 2007;31:367-374.
14. Song JH, Humes HD: The bioartificial kidney in the treatment of acute kidney injury. Curr Drug Targets 2009;10:1227-1234.
15. Ronco C, Bellomo R: Continuous renal replacement therapy: evolution in technology and current nomenclature. Kidney Int Suppl 1998;66:S160-S164.
16. Ronco C, Ricci Z, De Backer D, Kellum JA, et al. Renal replacement therapy in acute kidney injury: controversy and consensus. Crit Care 2015;19:146.
17. Mottes T, Owens T, Niedner M, et al. Improving delivery of continuous renal replacement therapy: impact of a simulation-based educational intervention. Pediatr Crit Care Med 2013;14:747-754.
18. Przybyl H, Androwich I, Evans J: Using high-fidelity simulation to assess knowledge, skills, and attitudes in nurses performing CRRT. Nephrol Nurs J 2015;42:135-147; quiz 148.
19. Graham P, Lischer E. Nursing issues in renal replacement therapy: organization, manpower assessment, competency evaluation and quality improvement processes. Semin Dial 2011;24:183-187.
20. Benfield CB, Brummond P, Lucarotti A, et al. Applying lean principles to continuous renal replacement therapy processes. Am J Health Syst Pharm 2015;72:218-223.
21. VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, O'Connor TZ, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008;359:7-20.
22. Renal Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009;361:1627-1638.
23. Chow NH, Liu HS, Lee EI, et al. Significance of urinary epidermal growth factor and its receptor expression in human bladder cancer. Anticancer Res 1997;17:1293-1296.
24. Kleger GR, Fässler E: Can circuit lifetime be a quality indicator in continuous renal replacement therapy in the critically ill? Int J Artif Organs 2010;33:139-146.
25. Perazella MA: The urine sediment as a biomarker of kidney disease. Am J Kidney Dis 2015;66:748-755.
26. Perazella MA, Coca SG, Hall IE, et al. Urine microscopy is associated with severity and worsening of acute kidney injury in hospitalized patients. Clin J Am Soc Nephrol 2010;5:402-408.
27. Pons B, Lautrette A, Oziel J, et al. Diagnostic accuracy of early urinary index changes in differentiating transient from persistent acute kidney injury in critically ill patients: multicenter cohort study. Crit Care 2013;17:R56.
28. Bagshaw SM, Langenberg C, Bellomo R: Urinary biochemistry and microscopy in septic acute renal failure: a systematic review. Am J Kidney Dis 2006;48:695-705.
29. Keyserling HF, Fielding JR, Mittelstaedt CA: Renal sonography in the intensive care unit: when is it necessary? J Ultrasound Med 2002;21:517-520.
30. Endre ZH, Kellum JA, Di Somma S, et al. Differential diagnosis of AKI in clinical practice by functional and damage biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol 2013;182:30-44.
31. Koyner JL, Davison DL, Brasha-Mitchell E, et al. Furosemide stress test and biomarkers for the prediction of AKI severity. J Am Soc Nephrol 2015;26:2023-2031.
32. Prowle JR, Kirwan CJ, Bellomo R: Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol 2014;10:37-47.
33. Hoste EA, Maitland K, Brudney CS, et al. Four phases of intravenous fluid therapy: a conceptual model. Br J Anaesth 2014;113:740-747.
34. Faubel S, Shah PB: Immediate consequences of acute kidney injury: the impact of traditional and nontraditional complications on mortality in acute kidney injury. Adv Chronic Kidney Dis 2016;23:179-185.
35. Teixeira C, Garzotto F, Piccinni P, et al. Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care 2013;17:R14.
36. Bouchard J, Soroko SB, Chertow GM, et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 2009;76:422-427.
37. Hobson C, Ozrazgat-Baslanti T, Kuxhausen A, et al. Cost and mortality associated with postoperative acute kidney injury. Ann Surg 2015;261:1207-1214.
38. Hobson C, Singhania G, Bihorac A: Acute kidney injury in the surgical patient. Crit Care Clin 2015;31:705-723.
39. Ozrazgat-Baslanti T, Thottakkara P, Huber M, et al. Acute and chronic kidney disease and cardiovascular mortality after major surgery. Ann Surg 2016, Epub ahead of print.
40. Jhaveri KD, Perazella MA: Nephrologists as educators: clarifying roles, seizing opportunities. Clin J Am Soc Nephrol 2016;11:176-189.
41. Hoste EA, Bagshaw SM, Bellomo R, Cely CM, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 2015;41:1411-1423.
42. Ali T, Khan I, Simpson W, et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol 2007;18:1292-1298.
43. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl (2011) 2012;2:1-141.
44. Bihorac A, Brennan M, Ozrazgat-Baslanti T, et al. National surgical quality improvement program underestimates the risk associated with mild and moderate postoperative acute kidney injury. Crit Care Med 2013;41:2570-2583.
45. Korenkevych D, Ozrazgat-Baslanti T, Thottakkara P, et al. The pattern of longitudinal change in serum creatinine and 90-day mortality after major surgery. Ann Surg 2016;263:1219-1227.
46. Kashani K, Al-Khafaji A, Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013;17:R25.
47. Koyner JL, Parikh CR: Clinical utility of biomarkers of AKI in cardiac surgery and critical illness. Clin J Am Soc Nephrol 2013;8:1034-1042.
48. Bihorac A, Chawla LS, Shaw AD, et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 2014;189:932-939.
49. Vaara ST, Reinikainen M, Wald R, et al. Timing of RRT based on the presence of conventional indications. Clin J Am Soc Nephrol 2014;9:1577-1585.
50. Wald R, Adhikari NK, Smith OM, et al. Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury. Kidney Int 2015;88:897-904.
51. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006;354:2564-2575.
52. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M: Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012;308:1566-1572.
53. Shaw AD, Bagshaw SM, Goldstein SL, et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg 2012;255:821-829.
54. Chawla LS, Davison DL, Brasha-Mitchell E, et al. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care 2013;17:R207.
55. Bihorac A: Guiding AKI prevention using biomarkers. Society of Critical Care Medicine. Crit Connect 2015;14:1.